Literature DB >> 9034328

Cytoplasmic domains of the common beta-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines.

A Smith1, D Metcalf, N A Nicola.   

Abstract

Granulocyte-macrophage colony stimulating factor (GM-CSF) is a cytokine that controls the production and function of myeloid cells by interaction with a cell surface receptor composed of a specific ligand-binding alpha-chain (hGMRalpha) and a shared signal-transducing beta-chain (beta c). Co-expression of human GMR alpha-chain and wild-type human beta c in two murine leukaemic cell lines (M1 and WEHI-3B D+) conferred the ability to terminally differentiate into macrophages when stimulated with human GM-CSF. Analysis of cytoplasmic truncation mutants of beta c showed that residues to amino acid 783 (numbering from the first amino acid of the leader sequence) were sufficient for the GM-CSF-dependent induction of all aspects of differentiation in both cell types. However, shorter truncations selectively lost, in a cell-specific manner, first the capacity to induce macrophage migration in agar and then cell surface differentiation antigens and clonal suppression of proliferative potential. The data suggest that different aspects of the differentiated phenotype can be dissociated with the required signalling pathways originating from distinct regions of the receptor cytoplasmic domain and cooperating to produce a fully differentiated macrophage. The cooperativity of these pathways and limiting cell signalling intermediate pool sizes could explain the observed cell line differences and may have implications for normal haemopoiesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034328      PMCID: PMC1169649          DOI: 10.1093/emboj/16.3.451

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Binding, internalization, and degradation of 125I-multipotential colony-stimulating factor (interleukin-3) by FDCP-1 cells.

Authors:  N A Nicola; D Metcalf
Journal:  Growth Factors       Date:  1988       Impact factor: 2.511

2.  Clonal suppression of HL60 and U937 cells by recombinant human leukemia inhibitory factor in combination with GM-CSF or G-CSF.

Authors:  T Maekawa; D Metcalf
Journal:  Leukemia       Date:  1989-04       Impact factor: 11.528

3.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

4.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

5.  Low-affinity placenta-derived receptors for human granulocyte-macrophage colony-stimulating factor can deliver a proliferative signal to murine hemopoietic cells.

Authors:  D Metcalf; N A Nicola; D P Gearing; N M Gough
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Purified colony stimulating factors (G-CSF and GM-CSF) induce differentiation in human HL60 leukemic cells with suppression of clonogenicity.

Authors:  C G Begley; D Metcalf; N A Nicola
Journal:  Int J Cancer       Date:  1987-01-15       Impact factor: 7.396

7.  Preparation of rat monoclonal antibodies to epitopes encoded by the viral oncogene (v-fms) of McDonough feline sarcoma virus.

Authors:  S J Anderson; M E Furth; L Wolff; S K Ruscetti; C J Sherr
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

8.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.

Authors:  U Klingmüller; U Lorenz; L C Cantley; B G Neel; H F Lodish
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

9.  Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor.

Authors:  D P Gearing; J A King; N M Gough; N A Nicola
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

10.  Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.

Authors:  J C Cerottini; H D Engers; H R Macdonald; T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  5 in total

1.  Towards predictive models of stem cell fate.

Authors:  Sowmya Viswanathan; Peter W Zandstra
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

2.  Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML.

Authors:  James Marvin; Suchitra Swaminathan; Geoffrey Kraker; Amy Chadburn; James Jacobberger; Charles Goolsby
Journal:  Blood       Date:  2011-01-13       Impact factor: 22.113

3.  The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation.

Authors:  Anna L Brown; Diana G Salerno; Teresa Sadras; Grant A Engler; Chung H Kok; Christopher R Wilkinson; Saumya E Samaraweera; Timothy J Sadlon; Michelle Perugini; Ian D Lewis; Thomas J Gonda; Richard J D'Andrea
Journal:  Differentiation       Date:  2011-10-08       Impact factor: 3.880

4.  Divergent effects of Wnt5b on IL-3- and GM-CSF-induced myeloid differentiation.

Authors:  Marina Mastelaro de Rezende; John-Poul Ng-Blichfeldt; Giselle Zenker Justo; Edgar Julian Paredes-Gamero; Reinoud Gosens
Journal:  Cell Signal       Date:  2019-12-17       Impact factor: 4.315

5.  Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity.

Authors:  Mayra Cecilia Suárez-Arriaga; Alfonso Méndez-Tenorio; Vadim Pérez-Koldenkova; Ezequiel M Fuentes-Pananá
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.